We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZT icon
2101
Invesco New York AMT-Free Municipal Bond ETF
PZT
$139M
$15.1K ﹤0.01%
667
+95
+17% +$2.19K
MRVI icon
2102
Maravai LifeSciences
MRVI
$904M
$15.1K ﹤0.01%
2,774
+593
+27% +$3.81K
ARIS
2103
DELISTED
Aris Water Solutions
ARIS
$15.1K ﹤0.01%
630
+91
+17% +$1.98K
AUR icon
2104
Aurora
AUR
$13.7B
$15.1K ﹤0.01%
2,395
+2,155
+898% +$13.5K
IE icon
2105
Ivanhoe Electric
IE
$1.76B
$15.1K ﹤0.01%
1,996
+1,550
+348% +$14.3K
FIVN icon
2106
FIVE9
FIVN
$2.58B
$15K ﹤0.01%
369
+148
+67% +$5.34K
CYBR
2107
DELISTED
CyberArk
CYBR
$15K ﹤0.01%
45
+21
+88% +$6.38K
SOUN icon
2108
SoundHound AI
SOUN
$3.25B
$15K ﹤0.01%
+755
New +$7.27K
TMDX icon
2109
Transmedics
TMDX
$3.07B
$15K ﹤0.01%
240
+57
+31% +$5.31K
FLNG icon
2110
FLEX LNG
FLNG
$1.64B
$15K ﹤0.01%
652
-1,318
-67% -$31.9K
ADNT icon
2111
Adient
ADNT
$1.44B
$15K ﹤0.01%
868
+666
+330% +$13.3K
CGNX icon
2112
Cognex
CGNX
$10.8B
$14.9K ﹤0.01%
416
-233
-36% -$9.13K
ACH
2113
Accendra Health
ACH
$107M
$14.9K ﹤0.01%
1,139
-45
-4% -$600
VERX icon
2114
Vertex
VERX
$1.97B
$14.9K ﹤0.01%
279
+110
+65% +$5.33K
PK icon
2115
Park Hotels & Resorts
PK
$2.92B
$14.8K ﹤0.01%
1,054
+231
+28% +$3.39K
RKLB icon
2116
Rocket Lab Corp
RKLB
$50B
$14.8K ﹤0.01%
582
+518
+809% +$9.1K
MAN icon
2117
ManpowerGroup
MAN
$2.63B
$14.8K ﹤0.01%
256
-47
-16% -$2.99K
BBIO icon
2118
BridgeBio Pharma
BBIO
$16.6B
$14.8K ﹤0.01%
538
+92
+21% +$2.38K
JBI icon
2119
Janus International
JBI
$732M
$14.8K ﹤0.01%
2,007
+1,993
+14,236% +$16.4K
NLOP
2120
Net Lease Office Properties
NLOP
$170M
$14.6K ﹤0.01%
469
-57
-11% -$1.77K
BSY icon
2121
Bentley Systems
BSY
$10.7B
$14.6K ﹤0.01%
313
-187
-37% -$9.12K
DBD icon
2122
Diebold Nixdorf
DBD
$2.43B
$14.6K ﹤0.01%
339
+185
+120% +$8.33K
FJP icon
2123
First Trust Japan AlphaDEX Fund
FJP
$259M
$14.6K ﹤0.01%
+282
New +$14.8K
AMCX icon
2124
AMC Global Media
AMCX
$489M
$14.5K ﹤0.01%
1,469
-951
-39% -$8.41K
FOXF icon
2125
Fox Factory Holding Corp
FOXF
$884M
$14.5K ﹤0.01%
479
-120
-20% -$4.13K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.